After $1.6B blank-check deal, Hims & Hers plots expansion into more conditions January 21, 2021 Auto Bot biotech IPO, direct-to-consumer, IPO, Retail Health, Telehealth, Telemedicine 0 The three-year-old digital health startup began trading on the New York Stock Exchange on Thursday. It merged with a subsidiary of Oaktree Capital Management in a deal that valued the company at $1.6 billion.